Liquidia Corporation Common Stock vs Prudential Financial Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.5 (market cap $2.40B), while Prudential Financial Inc trades at $113.12 (market cap $39.13B). The key difference: Prudential Financial Inc is far larger — about 16.3× Liquidia Corporation Common Stock's market cap, and Prudential Financial Inc pays a 4.94% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Prudential Financial Inc for 146 Days on average.
| LQDA | PRU | |
|---|---|---|
Market Cap | $2.40B | $39.13B |
Volume | 2,857,547 | 1,369,167 |
Sector | Health | Financials |
52-Week High | $91.03 | $125.13 |
52-Week Low | $22.02 | $92.00 |
Typical Hold Time | 0 Days | 146 Days |
Enterprise Value | $2.30B | $67.90B |
Dividend Yield | — | 4.94% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Financial (PRU) trades at $113.49, showing minimal daily movement (+0.09%). The stock presents mixed signals with bearish technical indicators but fundamentally attractive valuation metrics including a P/E of 10.28 and P/S of 0.61. Recent earnings show two consecutive quarterly beats, while the company executes strategic initiatives including a $185 million Alexforbes stake sale and rebranding to Prudential Wealth Advisors.
PRU offers value investment appeal with strong profitability metrics (12.46% ROE) and dividend income potential, though facing headwinds from bearish technical trends and mixed analyst sentiment. The company's strategic focus on core businesses and cost reduction provides upside potential, while interest rate sensitivity and competitive pressures remain key monitoring points for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →